DOJ sues NYC nonprofit health system over payer contracts | Patient injected with acid in ‘never event’ earns settlement

In a complaint filed in federal court, the U.S. Department of Justice claims NewYork-Presbyterian Hospital uses its power of “scale, breadth and configuration” to control payer contracts, making it difficult for insurers to develop low-cost plans. The health system denies any wrongdoing.

The disturbing case highlights a series of process errors and cost-cutting measures that ultimately led to the “never event” accident. 

Led by a Quebec-based faith organization, a coalition of investors is asking a court to force UnitedHealth to provide details on the social impacts of its history of mergers and acquisitions. The lawsuit comes after the plaintiffs, all company shareholders, failed to get the proposal passed through internal channels. The Securities and Exchange Commission has also opted not to intervene. 

Ohio State University College of Medicine, Stanford University School of Medicine and UC San Diego School of Medicine all received letters this week where federal authorities are requesting details related to admissions, including standardized test scores, donor correspondence and more. The schools say they are already compliant with state and federal regulations. 

Almost two in five physicians suffered moral distress in the two weeks leading up to their being asked about it by researchers. That was a markedly larger slice than the team observed in the general U.S. working population. 

Teflyon Cameron’s sentence was announced on Monday. She pleaded guilty for her role in a scheme that sent kickbacks to doctors for medically unnecessary orders. The U.S. Department of Justice said the conspiracy went on for “several years."

The nonprofit said it intends to appeal the U.S. District Court’s decision, though it will comply with the ruling for now. Five Tenet hospitals filed the lawsuit in April 2025, accusing Leapfrog of issuing ratings via a pay-to-play model.

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

Decreased screening rates among different subgroups highlight the ongoing need for outreach strategies that target vulnerable populations, experts contend.